These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18653880)

  • 1. HIV/AIDS. The high cost of stolen funds.
    Cohen J
    Science; 2008 Jul; 321(5888):523. PubMed ID: 18653880
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS. Uganda confronts corruption, slowly.
    Cohen J
    Science; 2008 Jul; 321(5888):522-5. PubMed ID: 18653879
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV/AIDS. Botswana's success comes at steep cost.
    Cohen J
    Science; 2008 Jul; 321(5888):526-9. PubMed ID: 18653882
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV/AIDS. The Global Fund's best friend?
    Cohen J
    Science; 2008 Jul; 321(5888):524. PubMed ID: 18653881
    [No Abstract]   [Full Text] [Related]  

  • 6. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 7. Time to move on HIV/AIDS treatment and care.
    Schwartländer B; Lange JM
    IAPAC Mon; 2003 Jan; 9(1):6-7. PubMed ID: 12712942
    [No Abstract]   [Full Text] [Related]  

  • 8. An unequal activism for an unequal epidemic?
    Selemogo M
    Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapies. The high cost of poverty.
    Cohen J
    Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
    [No Abstract]   [Full Text] [Related]  

  • 10. Public-private partnerships and antiretroviral drugs for HIV/AIDS: lessons from Botswana.
    Ramiah I; Reich MR
    Health Aff (Millwood); 2005; 24(2):545-51. PubMed ID: 15757942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. $15 million for infrastructure but no AIDS drugs for Jamaica.
    GMHC Treat Issues; 2003 Mar; 17(3):9-10. PubMed ID: 12728859
    [No Abstract]   [Full Text] [Related]  

  • 12. Uganda leads way in innovative HIV/AIDS treatment.
    Wendo C
    Bull World Health Organ; 2005 Apr; 83(4):244-5. PubMed ID: 15868011
    [No Abstract]   [Full Text] [Related]  

  • 13. Funding for HIV/AIDS needs to double to ensure universal access to drugs.
    Dyer C
    BMJ; 2009 Feb; 338():b583. PubMed ID: 19211637
    [No Abstract]   [Full Text] [Related]  

  • 14. A growing dichotomy: the gap between therapeutic haves and have-nots.
    AIDS Alert; 1998 Jan; 13(1):1-4. PubMed ID: 11364861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
    Maher D; von Schoen-Angerer T; Cohn J
    Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
    [No Abstract]   [Full Text] [Related]  

  • 16. PEPFAR claims gains in global fight against AIDS.
    AIDS Policy Law; 2007 May; 22(10):2. PubMed ID: 17619264
    [No Abstract]   [Full Text] [Related]  

  • 17. HHS announces $710 million in grants for HIV/AIDS care.
    Sweeney R; Rose VL
    Am Fam Physician; 1999 May; 59(9):2403. PubMed ID: 10323349
    [No Abstract]   [Full Text] [Related]  

  • 18. Global AIDS conference finds the issue is cash.
    Cullinan K
    Bull World Health Organ; 2002; 80(9):761-2. PubMed ID: 12378299
    [No Abstract]   [Full Text] [Related]  

  • 19. Uganda cuts AIDS drug deal.
    IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV/AIDS: money matters.
    Roberts L; Jasny B
    Science; 2008 Jul; 321(5888):511. PubMed ID: 18653875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.